PROGRAM

17:00

Conference opening

Otvaranje kongresa

17:00 – 17:45

Chronic hepatitis C – the feasibility of elimination by 2030 in the COVID-19 era

Kronični hepatitis C – realnost eliminacije do 2030. u pandemiji COVID-19

Antons Mozalevskis, Adriana Vince

17:45 – 18:30

Civil Society Role in Chronic Viral Hepatitis Elimination / Workshop organized by HEPATOS and HUHIV

Uloga civilnog društva u eliminaciji kroničnih virusnih hepatitisa / Radionica u organizaciji Društva HEPATOS i Udruge HUHIV

Maja Erceg Tušek, Tatjana Reić

18:30 – 19:00

Sponsored symposium

Sponzorirani simpozij

Medicopharmacia / Gilead

Sofosbuvir/velpatasvir: a simple and effective treatment option for almost everybody

Sofosbuvir/velpatasvir: jednostavna i učinkovita opcija liječenja za gotovo svakog

Alessandra Mangia

09:00 – 10:30

Chronic hepatitis B and D – can new drugs cure the infection?

Kronični hepatitis B i D – donose li novi lijekovi izlječenje?

Moderator: Adriana Vince

New drugs in hepatitis B

Novi lijekovi za hepatitis B

Maria Buti

Treatment of HDV: transition into a new era soon?

Liječenje hepatitisa D: nova era na vidiku?

Cihan Yurdaydin

The importance of drug-drug interactions in hepatology

Važnost interakcija lijekova u hepatologiji

David Back

10:30 – 11:30

Sponsored symposium

Sponzorirani simpozij

Medicopharmacia / Gilead

HCV Elimination – Solutions for New Challenges

Eliminacija kroničnog hepatitisa C – rješenja za nove izazove

Moderator: Adriana Vince

Role of addictology care in HCV Elimination Context

Uloga adiktološke skrbi u kontekstu eliminacije kroničnog hepatitisa C

Zoran Zoričić

Importance of early screening of HCV

Provedba aktivnosti ranog dijagnosticiranja oboljelih od kroničnog hepatitis C

Boris Lukšić

HCV treatment in times of COVID-19 pandemics

Liječenje kroničnog hepatitisa C tijekom COVID-19 pandemije

Adriana Vince

Discussion

Rasprava

12:00 – 12:45

Moderators / Moderatori: Davorka Dušek, Neven Papić

Liver in COVID-19

Jetra i COVID-19

Mario Mondelli

12:45 – 13:00

Sponsored symposium

Sponzorirani simpozij

Pfizer

Treatment of invasive aspergillosis and mucormycosis with Cresemba (isavuconasol)

Liječenje invazivne aspergiloze i mukormikoze Cresembom (izavukonazol)

Marija Santini

13:00 – 14:00

Break

Pauza

14:00 – 15:30

The story of NAFLD revisited

Nove spoznaje o NAFLD-u

Moderator: Lucija Virović Jukić

NAFLD – more than just a fatty liver

NAFLD – više od masne jetre

Tajana Filipec Kanižaj

Update of NAFLD/NASH diagnostics

Novosti u dijagnostici NAFLD/NASH

Ivica Grgurević

2020 standard of care treatment

Liječenje NAFLD-a 2020.

Nermin Salkić

Discussion

Rasprava

15:45 – 17:15

Clinical nutrition of patients with chronic liver diseases

Klinička prehrana bolesnika s kroničnim bolestima jetre

Moderator: Željko Krznarić

Nutritional issues in cholestatic liver diseases

Klinička prehrana kod bolesnika s kolestatskom bolesti jetre

Željko Krznarić

Sarcopenia, obesity and nutrition support in NAFLD

Sarkopenija, pretilost i klinička prehrana u NAFLD-u

Darija Vranešić Bender

What about parenteral nutrition in chronic liver diseases?

Bolesti jetre uzrokovane parenteralnom prehranom

Dina Ljubas Kelečić

Discussion

Rasprava

17:15 – 18:00

Sponsored symposium

Sponzorirani simpozij

MSD

Challenges of HCV care in the national hospitals during COVID-19

Izazovi u liječenju hepatitisa C u nacionalnim bolnicama tijekom COVID-a 19

Panelisti: Adriana Vince, Marieta Simonova, Tajana Filipec Kanižaj, Davorka Dušek

09:00 – 10:00

Sponsored symposium

Sponzorirani simpozij

Abbvie

Moderator: Adriana Vince

HCV EASL Guidelines

HCV EASL smjernice

Lucija Virović-Jukić

Treatment of HCV from a primary care perspective

Liječenje HCV iz perspektive primarne zdravstvene zaštite

Ante Ivančić

Activities of hepatitis outpatient department – collaboration with family physicians

Aktivnost hepatalne non-COVID ambulante – suradnja s liječnicima obiteljske medicine

Ivan Kurelac

Discussion

Rasprava

10:00 – 11:00

Hepatitis A and E, still around

Hepatitis A i E, još uvijek aktualne bolesti

Moderator: Snježana Židovec Lepej

Viral hepatitis A – how to prevent outbreaks

Virusni hepatitis A – kako spriječiti epidemije

Tatjana Nemeth Blažić, Mirjana Lana Kosanović Ličina

Viral hepatitis E – problem in transplantation medicine?

Viral hepatitis E – problem u transplantacijskoj medicini?

Anna Mrzljak

Discussion

Rasprava

11:00 – 11:30

Imaging techniques in liver diseases

Slikovne tehnike u bolestima jetre

Boris Brkljačić

11:30 – 12:00

Treatment of HCC in 2020

Liječenje HCC-a u 2020.

Stjepko Pleština

12:00 – 12:30

Liver infections in immunocompromised patients

Infekcije jetre kod imunokompromitiranih bolesnika

Josip Begovac

12:30 – 13:30

Break

Pauza

WORKSHOPS – “Case based problem solving”

RADIONICE – “Prikaz slučaja”

13:30 – 14:30

WORKSHOP 1 / Diagnostics and treatment of viral hepatitis

RADIONICA 1 / Novosti u dijagnostici i liječenju kroničnih virusnih hepatitisa

Moderator: Mario Poljak

Case presenter / Prezenter slučaja: Ivan Kurelac, Jelena Budimir

14:30 – 15:30

WORKSHOP 2 / Imaging of liver diseases

RADIONICA 2 / Slikovni prikaz bolesti jetre

Moderator: Klaudija Višković

Case presenters / Prezenteri slučaja: Lucija Virović Jukić, Juraj Krznarić

15:30 – 16:30

WORKSHOP 3 / Differential diagnosis of inflammatory liver diseases

RADIONICA 3 / Diferencijalna dijagnoza upalnih bolesti jetre

Moderator: Ivana Štromar Knežević

Case presenters / Prezenteri slučaja: Davorka Dušek, Vibor Šeša

16:30 – 17:15

Sponsored symposium

Sponzorirani simpozij

MSD

Treatment and Care of HIV Infected Persons Coinfected with Hepatitis C Virus

Liječenje i skrb osoba zaraženih HIV-om koinficiranih virusom hepatitisa C

Panelisti: Davorka Lukas, Josip Begovac, Šime Zekan, Sanja Belak Škugor

Conference closing

Zatvaranje kongresa

Adriana Vince, Neven Papić